Cover Image
市場調查報告書

末梢血管支架:醫療設備的開發平台評估

Peripheral Vascular Stents - Medical Devices Pipeline Assessment, 2018

出版商 GlobalData 商品編碼 223329
出版日期 內容資訊 英文 245 Pages
訂單完成後即時交付
價格
Back to Top
末梢血管支架:醫療設備的開發平台評估 Peripheral Vascular Stents - Medical Devices Pipeline Assessment, 2018
出版日期: 2018年06月14日 內容資訊: 英文 245 Pages
簡介

本報告提供全球末梢血管支架市場上的主要開發中產品 (醫療設備) 及其臨床實驗的進展調查,再彙整產品特性比較分析 (臨床實驗的各進展階段) ,再加上主要企業簡介及代表性產品,近來的市場動靜 (資本交易·產業聯盟等) 等資訊,為您概述為以下內容。

第1章 目錄

第2章 簡介

  • 末梢血管支架概要

第3章 現在臨床實驗中的產品

  • 開發中產品:各臨床實驗階段
  • 開發中產品:各市場區隔
  • 開發中產品:各領域
  • 開發中產品:各法規途徑
  • 開發中產品:各估計認證時期
  • 現在進行中的臨床實驗

第4章 末梢血管支架心臟:各企業現在臨床實驗中的開發中產品

  • 末梢血管支架的企業:各臨床實驗階段的開發中產品
  • 末梢血管支架:各臨床實驗階段的開發中產品

第5章 末梢血管支架的企業·產品概要

  • 3D Biotek LLC
  • 480 Biomedical In
  • Abbott Vascular Inc.
  • Biotronik SE & Co KG
  • Boston Scientific Corp
  • C. R. Bard Inc
  • Cardiatis SA
  • Cook Medical Inc
  • Cordis Corp
  • Corinnova Inc
  • Cytograft Tissue Engineering Inc
  • Efferent Labs Inc
  • Electroformed Stents Inc
  • Elixir Medical Corp
  • Hexacath
  • InspireMD Inc
  • Intact Vascular, LLC
  • Lifetech Scientific (Shenzhen) Co., Ltd
  • LimFlow GmbH
  • Medinol Ltd
  • Medtronic plc
  • MicroVention, Inc.
  • Natec Medical Ltd
  • Nexeon MedSystems Inc
  • Nipro
  • Northwestern University
  • NSVascular, Inc.
  • PeriTec Biosciences Ltd
  • Stron Medical
  • Synergy Flow Ltd
  • Taewoong Medical Co.,Ltd.
  • Tepha Inc
  • TissueGen Inc
  • University of Michigan
  • University of Texas Medical Branch at Galveston
  • Vascular Bioresorbable Technologies
  • Vascular Concepts Ltd
  • Veniti Inc
  • Veryan Medical Limited
  • VueKlar Cardiovascular Ltd
  • Xenogenics Corporation

第6章 末梢血管支架市場:目前的趨勢 (全77件)

第7章 建議

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0580EPD

GlobalData's Medical Devices sector report, "Peripheral Vascular Stents - Medical Devices Pipeline Assessment, 2018" provides an overview of Peripheral Vascular Stents currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Peripheral Vascular Stents pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Peripheral Vascular Stents under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Peripheral Vascular Stents and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Peripheral Vascular Stents under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 6
  • 1.2 List of Figures 11

2 Introduction 12

  • 2.1 Peripheral Vascular Stents Overview 12

3 Products under Development 13

  • 3.1 Peripheral Vascular Stents - Pipeline Products by Stage of Development 13
  • 3.2 Peripheral Vascular Stents - Pipeline Products by Segment 14
  • 3.3 Peripheral Vascular Stents - Pipeline Products by Territory 15
  • 3.4 Peripheral Vascular Stents - Pipeline Products by Regulatory Path 16
  • 3.5 Peripheral Vascular Stents - Pipeline Products by Estimated Approval Date 17
  • 3.6 Peripheral Vascular Stents - Ongoing Clinical Trials 18

4 Peripheral Vascular Stents - Pipeline Products under Development by Companies 19

  • 4.1 Peripheral Vascular Stents Companies - Pipeline Products by Stage of Development 19
  • 4.2 Peripheral Vascular Stents - Pipeline Products by Stage of Development 21

5 Peripheral Vascular Stents Companies and Product Overview 24

  • 5.1 3D Biotek LLC Company Overview 24
  • 5.2 480 Biomedical Inc Company Overview 25
  • 5.3 Abbott Vascular Inc Company Overview 27
  • 5.4 AndraTec GmbH Company Overview 30
  • 5.5 Becton Dickinson and Co Company Overview 31
  • 5.6 Boston Scientific Corp Company Overview 32
  • 5.7 C. R. Bard Inc Company Overview 39
  • 5.8 Cardiatis SA Company Overview 40
  • 5.9 Cook Medical Inc Company Overview 41
  • 5.10 Cordis Corp Company Overview 46
  • 5.11 Corinnova Inc Company Overview 51
  • 5.12 Cytograft Tissue Engineering Inc (Inactive) Company Overview 52
  • 5.13 Efferent Labs Inc Company Overview 53
  • 5.14 Electroformed Stents Inc Company Overview 54
  • 5.15 Elixir Medical Corp Company Overview 56
  • 5.16 FIT Biotech Oy Company Overview 59
  • 5.17 ID Nest Medical SAS Company Overview 61
  • 5.18 InspireMD Inc Company Overview 62
  • 5.19 Intact Vascular LLC Company Overview 63
  • 5.20 LimFlow GmbH Company Overview 68
  • 5.21 Medtronic plc Company Overview 71
  • 5.22 Micell Technologies Inc Company Overview 74
  • 5.23 Natec Medical Ltd Company Overview 75
  • 5.24 Nipro Corp Company Overview 76
  • 5.25 NSVascular, Inc. Company Overview 77
  • 5.26 PeriTec Biosciences Ltd Company Overview 78
  • 5.27 QualiMed Innovative Medizinprodukte GmbH Company Overview 80
  • 5.28 Qvanteq AG Company Overview 83
  • 5.29 REVA Medical Inc Company Overview 84
  • 5.30 Stron Medical Company Overview 85
  • 5.31 Synergy Flow Ltd Company Overview 86
  • 5.32 Taewoong Medical Co Ltd Company Overview 87
  • 5.33 Tepha Inc Company Overview 95
  • 5.34 Terumo Corp Company Overview 96
  • 5.35 TissueGen Inc Company Overview 97
  • 5.36 University of Michigan Company Overview 98
  • 5.37 University of Pittsburgh Medical Center Company Overview 99
  • 5.38 Vascular Bioresorbable Technologies Company Overview 100
  • 5.39 Vascular Concepts Ltd Company Overview 102
  • 5.40 Vascular Dynamics Ltd. Company Overview 105
  • 5.41 Veniti Inc Company Overview 109
  • 5.42 Veryan Medical Ltd Company Overview 112
  • 5.43 Vesper Medical Inc Company Overview 115
  • 5.44 VueKlar Cardiovascular Ltd (Inactive) Company Overview 116
  • 5.45 Wake Forest University Health Sciences Company Overview 118
  • 5.46 Xenogenics Corporation Company Overview 119
  • 5.47 Zorion Medical Company Overview 121

6 Peripheral Vascular Stents- Recent Developments 122

  • 6.1 Jun 01, 2018: Boston Scientific Announces Scheduled Presentations At Digestive Disease Week 2018 122
  • 6.2 May 31, 2018: Merit Medical Announces Leadership Change and Appointment of Interim CFO 123
  • 6.3 May 24, 2018: Medtronic Reports Fourth Quarter And Fiscal Year 2018 Financial Results 123
  • 6.4 May 15, 2018: Getinge announces its commitment to EuroPCR 125
  • 6.5 May 11, 2018: Terumo Appoints its U.S.-based Subsidiary's Associate as the Fifth Terumo Fellow 126
  • 6.6 May 10, 2018: Neovasc Announces Results for the First Quarter 2018 126
  • 6.7 May 07, 2018: Medtronic Appoints Mike Weinstein As Senior Vice President Of Strategy 129
  • 6.8 May 04, 2018: Ross Harvey named new director of global Customer Support & Delivery at Cook Medical 130
  • 6.9 May 03, 2018: Intact Vascular Announces Enrollment Completion of the Tack Optimized Balloon Angioplasty III (TOBA III) Clinical Trial 131
  • 6.10 Apr 25, 2018: Merit Medical Reports First Quarter of 2018 Financial Results 131
  • 6.11 Apr 25, 2018: Boston Scientific Reports Financial Results For First Quarter 2018 132
  • 6.12 Apr 25, 2018: CONMED Announces First Quarter 2018 Financial Results 134
  • 6.13 Apr 25, 2018: Xianjian Technology Receives the Most Attention from Institutional Investors 135
  • 6.14 Apr 24, 2018: Edwards Lifesciences Announces First Quarter 2018 Financial Results 136
  • 6.15 Apr 20, 2018: Cook Medical Appoints Christina Anne Vice President of Distribution Channel Management 137
  • 6.16 Apr 18, 2018: Abbott Reports First-Quarter 2018 Results 138
  • 6.17 Apr 12, 2018: STENTYS: Financial Information for the First Quarter of 2018 140
  • 6.18 Apr 05, 2018: Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics 141
  • 6.19 Mar 29, 2018: AngioDynamics Reports Fiscal 2018 Third Quarter Financial Results 142
  • 6.20 Mar 28, 2018: Neovasc Announces Results for the Fourth Quarter and Fiscal Year 2017 143
  • 6.21 Mar 27, 2018: Intact Vascular Welcomes TOBA BTK Trial One-Year Clinical Study Results Publication in Catheterization and Cardiovascular Intervention 147
  • 6.22 Mar 01, 2018: Researchers from MIPT study a nanoscaffold for heart cells 148
  • 6.23 Feb 28, 2018: Merit Medical Reports Results for Fourth Quarter and Year Ended December 31, 2017; Merit Meets Range of 2017 Guidance; Gives 2018 Guidance 149
  • 6.24 Feb 08, 2018: Terumo Revises the Full-Year Results Forecast for FY 2017 150
  • 6.25 Feb 01, 2018: Boston Scientific Announces Results for Fourth Quarter and Full Year 2017 151
  • 6.26 Feb 01, 2018: Edwards Lifesciences Reports Fourth Quarter Results 153
  • 6.27 Jan 31, 2018: LINC 2018: BIOTRONIK presents excellent 12-month data on more than 1000 patients 154
  • 6.28 Jan 31, 2018: CONMED Announces Fourth Quarter and Fiscal Year 2017 Financial Results 155
  • 6.29 Jan 30, 2018: Surgeon Saves Patient's Foot From Amputation Using new LimFlow Procedure 156
  • 6.30 Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region 158
  • 6.31 Jan 29, 2018: LimFlow Completes Enrollment In US Feasibility Study and Receives Breakthrough Device Status from FDA for Its Percutaneous Deep Vein Arterialization System 158
  • 6.32 Jan 26, 2018: Medtronic Launches IDE Study to Evaluate the Abre Venous Self-Expanding Stent System in Patients with Deep Venous Disease 159
  • 6.33 Jan 25, 2018: Veracyte Announces 100,000th Afirma Test Performed to Reduce Unnecessary Surgeries in Thyroid Cancer Diagnosis 160
  • 6.34 Jan 25, 2018: TOBA II BTK Trial Enrollment Ahead of Schedule for the Tack Endovascular System in Below the Knee Disease 161
  • 6.35 Jan 25, 2018: Terumo Announces Change of Directors and Executive Officers 161
  • 6.36 Jan 24, 2018: Abbott Reports Fourth-Quarter 2017 Results 163
  • 6.37 Jan 22, 2018: Neovasc Appoints Fred Colen As Chief Executive Officer 166
  • 6.38 Jan 09, 2018: Boston Scientific Announces Preliminary Unaudited Sales For The Fourth Quarter And Full Year Ended December 31, 2017 167
  • 6.39 Jan 08, 2018: STENTYS Reports Revenues for the Fourth Quarter and Full Year 2017 168
  • 6.40 Jan 07, 2018: LifeTech Scientific and Ally Bridge Group Form China-Global Medtech Investment and Operating Partnership 168
  • 6.41 Jan 04, 2018: AngioDynamics Reports Fiscal 2018 Second Quarter Financial Results 169
  • 6.42 Jan 03, 2018: Tryton Medical Announces New CEO and President 170
  • 6.43 Jan 02, 2018: CONMED Appoints Todd W. Garner as Executive Vice President and Chief Financial Officer 171

7 Appendix 241

  • 7.1 Methodology 241
  • 7.2 About GlobalData 244
  • 7.3 Contact Us 244
  • 7.4 Disclaimer 244

List of Tables

1.1 List of Tables

  • Table 1: Peripheral Vascular Stents - Pipeline Products by Stage of Development 14
  • Table 2: Peripheral Vascular Stents - Pipeline Products by Segment 15
  • Table 3: Peripheral Vascular Stents - Pipeline Products by Territory 16
  • Table 4: Peripheral Vascular Stents - Pipeline Products by Regulatory Path 17
  • Table 5: Peripheral Vascular Stents - Pipeline Products by Estimated Approval Date 18
  • Table 6: Peripheral Vascular Stents - Ongoing Clinical Trials 19
  • Table 7: Peripheral Vascular Stents Companies - Pipeline Products by Stage of Development 20
  • Table 8: Peripheral Vascular Stents - Pipeline Products by Stage of Development 22
  • Table 9: 3D Biotek LLC Pipeline Products & Ongoing Clinical Trials Overview 25
  • Table 10: Bioresorbable Drug Eluting Peripheral Polymer Stent - Product Status 25
  • Table 11: Bioresorbable Drug Eluting Peripheral Polymer Stent - Product Description 25
  • Table 12: 480 Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 26
  • Table 13: Stanza Bioresorbable Pediatric Scaffold - Product Status 26
  • Table 14: Stanza Bioresorbable Pediatric Scaffold - Product Description 26
  • Table 15: Stanza Bioresorbable Self-Expanding Scaffold - Product Status 27
  • Table 16: Stanza Bioresorbable Self-Expanding Scaffold - Product Description 27
  • Table 17: Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview 28
  • Table 18: ESPRIT Bioresorbable Vascular Scaffold - Product Status 28
  • Table 19: ESPRIT Bioresorbable Vascular Scaffold - Product Description 28
  • Table 20: Abbott Vascular Inc - Ongoing Clinical Trials Overview 29
  • Table 21: ESPRIT Bioresorbable Vascular Scaffold - Observational Study of Treatment of Bioresorbable Vascular Scaffolds Restenosis 30
  • Table 22: ESPRIT Bioresorbable Vascular Scaffold - Safety and Feasibility of Bioabsorbable Everolimus-Eluting Stents for Patients with Internal Pudendal Artery-related Arteriogenic Erectile Dysfunction (PERFECT-ABSORB) 30
  • Table 23: AndraTec GmbH Pipeline Products & Ongoing Clinical Trials Overview 31
  • Table 24: Pillar Bifurcation Reconstruction Device - Product Status 31
  • Table 25: Pillar Bifurcation Reconstruction Device - Product Description 31
  • Table 26: Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview 32
  • Table 27: LifeStent ProSeries Stent - Product Status 32
  • Table 28: LifeStent ProSeries Stent - Product Description 32
  • Table 29: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 33
  • Table 30: Eluvia Drug-Eluting Vascular Stent System - Product Status 33
  • Table 31: Eluvia Drug-Eluting Vascular Stent System - Product Description 33
  • Table 32: Gallbladder Drainage System - Product Status 34
  • Table 33: Gallbladder Drainage System - Product Description 34
  • Table 34: SAVAL Drug Eluting Stent BTK - Product Status 34
  • Table 35: SAVAL Drug Eluting Stent BTK - Product Description 34
  • Table 36: Wallstent RP Endoprosthesis - Venous Outflow Obstruction - Product Status 35
  • Table 37: Wallstent RP Endoprosthesis - Venous Outflow Obstruction - Product Description 35
  • Table 38: Boston Scientific Corp - Ongoing Clinical Trials Overview 36
  • Table 39: Eluvia Drug-Eluting Vascular Stent System - A Randomized Trial Comparing the ELUVIA Drug-eluting Stent Versus Bare Metal Self-expanding Nitinol Stents in the Treatment of Superficial Femoral and/or Proximal Popliteal Arteries 37
  • Table 40: Eluvia Drug-Eluting Vascular Stent System - A Randomized Trial Comparing the ELUVIA Drug-eluting Stent Versus Zilver PTX Stent for Treatment of Superficial Femoral and/or Proximal Popliteal Arteries 37
  • Table 41: Eluvia Drug-Eluting Vascular Stent System - A Real World Evaluation of the ELUVIA Drug Eluting Stent in All-comers with Superficial Femoral Artery and Proximal Popliteal Artery Disease 37
  • Table 42: Eluvia Drug-Eluting Vascular Stent System - Sequent Please Drug Coated Balloons Versus Primary Stent Application in Long SFA Lesions 38
  • Table 43: Wallstent RP Endoprosthesis - Venous Outflow Obstruction - Sinai Vein Stent Registry 39
  • Table 44: C. R. Bard Inc Pipeline Products & Ongoing Clinical Trials Overview 40
  • Table 45: VENOVO Venous Stent - Product Status 40
  • Table 46: VENOVO Venous Stent - Product Description 40
  • Table 47: Cardiatis SA Pipeline Products & Ongoing Clinical Trials Overview 41
  • Table 48: Cardiatis FluidSmart 3D Stent - Product Status 41
  • Table 49: Cardiatis FluidSmart 3D Stent - Product Description 41
  • Table 50: Cook Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 42
  • Table 51: Evolution Biliary Stent System-Partially Covered - Product Status 42
  • Table 52: Evolution Biliary Stent System-Partially Covered - Product Description 42
  • Table 53: Zenith Connection Endovascular Covered Stent - Product Status 43
  • Table 54: Zenith Connection Endovascular Covered Stent - Product Description 43
  • Table 55: Zilver Vena Venous Self-Expanding Stent - Product Status 43
  • Table 56: Zilver Vena Venous Self-Expanding Stent - Product Description 44
  • Table 57: Cook Medical Inc - Ongoing Clinical Trials Overview 45
  • Table 58: Zilver Vena Venous Self-Expanding Stent - Evaluation of the Zilver Vena Venous Stent in the Treatment of Symptomatic Iliofemoral Venous Outflow Obstruction 46
  • Table 59: Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview 47
  • Table 60: FlexStent Femoropopliteal Self Expanding Stent System - SFA - Product Status 47
  • Table 61: FlexStent Femoropopliteal Self Expanding Stent System - SFA - Product Description 48
  • Table 62: FlexStent Self Expanding Below-The-Knee Venous Stent System - Product Status 48
  • Table 63: FlexStent Self Expanding Below-The-Knee Venous Stent System - Product Description 48
  • Table 64: FlexStent Self Expanding Venous Stent System - Product Status 49
  • Table 65: FlexStent Self Expanding Venous Stent System - Product Description 49
  • Table 66: Tibial SE FlexStent - Product Status 49
  • Table 67: Tibial SE FlexStent - Product Description 49
  • Table 68: Cordis Corp - Ongoing Clinical Trials Overview 50
  • Table 69: FlexStent Femoropopliteal Self Expanding Stent System - SFA - Evaluation of Safety and Efficacy of the FlexStent Femoropopliteal Self-expanding Stent System Study 51
  • Table 70: Corinnova Inc Pipeline Products & Ongoing Clinical Trials Overview 52
  • Table 71: Hybrid Dynamic Stent - Product Status 52
  • Table 72: Hybrid Dynamic Stent - Product Description 52
  • Table 73: Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 53
  • Table 74: LifeJacket Stent Graft - Peripheral - Product Status 53
  • Table 75: LifeJacket Stent Graft - Peripheral - Product Description 53
  • Table 76: Efferent Labs Inc Pipeline Products & Ongoing Clinical Trials Overview 54
  • Table 77: RTI-LICD Plexisense - Product Status 54
  • Table 78: RTI-LICD Plexisense - Product Description 54
  • Table 79: Electroformed Stents Inc Pipeline Products & Ongoing Clinical Trials Overview 55
  • Table 80: Helical Stent - Product Status 55
  • Table 81: Helical Stent - Product Description 55
  • Table 82: Patch Stent - Product Status 56
  • Table 83: Patch Stent - Product Description 56
  • Table 84: Pleated Stent - Product Status 56
  • Table 85: Pleated Stent - Product Description 56
  • Table 86: Elixir Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 57
  • Table 87: PRAVA Bioresorbable Scaffold - Product Status 57
  • Table 88: PRAVA Bioresorbable Scaffold - Product Description 57
  • Table 89: Elixir Medical Corp - Ongoing Clinical Trials Overview 58
  • Table 90: PRAVA Bioresorbable Scaffold - Drug Eluting Scaffold with an Absorbable Platform for Primary Lower Extremity Arterial Revascularization: DESappear Study 59
  • Table 91: FIT Biotech Oy Pipeline Products & Ongoing Clinical Trials Overview 60
  • Table 92: GTU X-Stent - Product Status 60
  • Table 93: GTU X-Stent - Product Description 60
  • Table 94: GTU X2-Stent - Product Status 61
  • Table 95: GTU X2-Stent - Product Description 61
  • Table 96: ID Nest Medical SAS Pipeline Products & Ongoing Clinical Trials Overview 62
  • Table 97: ID Venous System - Product Status 62
  • Table 98: ID Venous System - Product Description 62
  • Table 99: InspireMD Inc Pipeline Products & Ongoing Clinical Trials Overview 63
  • Table 100: PVGuard Peripheral - Product Status 63
  • Table 101: PVGuard Peripheral - Product Description 63
  • Table 102: Intact Vascular LLC Pipeline Products & Ongoing Clinical Trials Overview 64
  • Table 103: Tack Endovascular System - ATK - Product Status 64
  • Table 104: Tack Endovascular System - ATK - Product Description 64
  • Table 105: Tack Endovascular System - BTK - Product Status 65
  • Table 106: Tack Endovascular System - BTK - Product Description 65
  • Table 107: Intact Vascular LLC - Ongoing Clinical Trials Overview 66
  • Table 108: Tack Endovascular System - ATK - Tack Optimized Balloon Angioplasty (TOBA) Study for Femoropopliteal Arteries Using the Tack-IT Endovascular Stapler 67
  • Table 109: Tack Endovascular System - ATK - Tack Optimized Balloon Angioplasty Study for Superficial Femoral and Proximal Popliteal Arteries Using the Tack Endovascular System 67
  • Table 110: Tack Endovascular System - ATK - Tack Optimized Drug Coated Balloon Angioplasty in the Superficial Femoral and Proximal Popliteal Arteries Using the Tack Endovascular System 67
  • Table 111: Tack Endovascular System - BTK - Tack Optimized Balloon Angioplasty Study for the below the Knee Arteries Using the Tack Endovascular System 68
  • Table 112: LimFlow GmbH Pipeline Products & Ongoing Clinical Trials Overview 69
  • Table 113: LimFlow Percutaneous Deep Vein Arterialisation System - Product Status 69
  • Table 114: LimFlow Percutaneous Deep Vein Arterialisation System - Product Description 69
  • Table 115: LimFlow GmbH - Ongoing Clinical Trials Overview 70
  • Table 116: LimFlow Percutaneous Deep Vein Arterialisation System - A Post-market Surveillance study of LimFlow System in the Treatment of Patients with End-stage Critical Limb Ischemia 71
  • Table 117: LimFlow Percutaneous Deep Vein Arterialisation System - Pilot Study to Investigate Safety, Effectiveness and Feasibility of LimFlow Stent Graft System for Creating an AV Fistula for the Treatment of Critical Limb Ischemia 71
  • Table 118: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 72
  • Table 119: Abre Venous Self-Expanding Stent System - Product Status 72
  • Table 120: Abre Venous Self-Expanding Stent System - Product Description 72
  • Table 121: Medtronic plc - Ongoing Clinical Trials Overview 73
  • Table 122: Abre Venous Self-Expanding Stent System - A Safety and Effectiveness of the Abre Stent System in Patients with Iliofemoral Venous Outflow Obstruction 74
  • Table 123: Micell Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 75
  • Table 124: Peripheral Drug-Eluting Stent - Product Status 75
  • Table 125: Peripheral Drug-Eluting Stent - Product Description 75
  • Table 126: Natec Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 76
  • Table 127: Marina - Product Status 76
  • Table 128: Marina - Product Description 76
  • Table 129: Nipro Corp Pipeline Products & Ongoing Clinical Trials Overview 77
  • Table 130: Peripheral Stent - Product Status 77
  • Table 131: Peripheral Stent - Product Description 77
  • Table 132: NSVascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview 78
  • Table 133: Micropatterned TFN Stent - Product Status 78
  • Table 134: Micropatterned TFN Stent - Product Description 78
  • Table 135: PeriTec Biosciences Ltd Pipeline Products & Ongoing Clinical Trials Overview 79
  • Table 136: Periteneum-Lined Balloon-Expandable Stent - Product Status 79
  • Table 137: Periteneum-Lined Balloon-Expandable Stent - Product Description 79
  • Table 138: Peritoneum Lined Self-Expanding Stent - Product Status 80
  • Table 139: Peritoneum Lined Self-Expanding Stent - Product Description 80
  • Table 140: QualiMed Innovative Medizinprodukte GmbH Pipeline Products & Ongoing Clinical Trials Overview 81
  • Table 141: Biliary 0.035" OTW Stent - Product Status 81
  • Table 142: Biliary 0.035" OTW Stent - Product Description 81
  • Table 143: SOZO With 0.014" PERSEUS-q PTA Balloon Catheter - Product Status 82
  • Table 144: SOZO With 0.014" PERSEUS-q PTA Balloon Catheter - Product Description 82
  • Table 145: Tracheobronchial Stent - Product Status 82
  • Table 146: Tracheobronchial Stent - Product Description 83
  • Table 147: Qvanteq AG Pipeline Products & Ongoing Clinical Trials Overview 84

List of Figures

1.2 List of Figures

  • Figure 1: Peripheral Vascular Stents - Pipeline Products by Stage of Development 14
  • Figure 2: Peripheral Vascular Stents - Pipeline Products by Segment 15
  • Figure 3: Peripheral Vascular Stents - Pipeline Products by Territory 16
  • Figure 4: Peripheral Vascular Stents - Pipeline Products by Regulatory Path 17
  • Figure 5: Peripheral Vascular Stents - Pipeline Products by Estimated Approval Date 18
  • Figure 6: Peripheral Vascular Stents - Ongoing Clinical Trials 19
Back to Top